Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Ophthalmologic Bevacizumab Formulation One Step Closer to FDA Approval
This week, Outlook Therapeutics announced positive clinical and highly significant top-line results from the phase 3 NORSE TWO safety and efficacy trial comparing bevacizumab with ranibizumab, sold as Lucentis, in the treatment of wet age-related macular degeneration (AMD).
As reported by Ophthalmology Times®, successful completion of the trial served as the final step needed in the clinical evaluation of bevacizumab to submit a Biologics License Application (BLA) to the FDA. These results add to the positive top-line results reported in 2 clinical trials earlier this year of bevacizumab, a full-length, humanized anti-vascular endothelial growth factor (VEGF) biosimilar for the treatment of wet AMD.
Outlook Therapeutics announced plans to submit a BLA in the first quarter of 2022. If approved, bevacizumab would become the first ophthalmologic formulation of bevacizumab to treat retinal conditions.
The originator drug, Avastin, is used off label currently for wet AMD.
Long COVID-19 Linked With Corneal Nerve Damage
Findings of an observational study suggest adverse events related to long COVID-19 may be detectable in the eyes of patients via nerve damage in the cornea and increased dendritic cells, according to Modern RetinaTM.
Examining patients through corneal confocal microscopy (CCM), those with neurological symptoms 4 weeks after acute COVID-19 exhibited lower corneal nerve parameters than controls. Moreover, patients with more severe cases of COVID-19 typically presented with greater corneal nerve damage.
However, these findings were observed in a small cohort and they could not confirm whether the virus caused the corneal abnormalities in patients. Pending further research on CCM, researchers noted that it could be used to objectively identify patients with long COVID-19, which affects up to 30% of patients after recovering from acute COVID-19 infection.
United Nations Adopts First-Ever Resolution on Vision
Seeking to improve access to eye care worldwide, the United Nations (UN) General Assembly announced the approval of its first-ever resolution on vision, called “Vision for Everyone,” which will be sponsored by Bangladesh, Antigua and Ireland, and co-sponsored by over 100 countries.
As reported by Ophthalmology Times®, the resolution was adopted late last month by the UN and will commit the organization to improving vision for 1.1 billion people living with preventable vision loss by 2030.
Encouraging all 193 member nations to adopt a federal approach to eye care, the UN resolution is also urging international financial institutions and donors to provide targeted financing to tackle the rising impact of vision loss on economic and social development.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen